Novartis revenue increased from $47.4 billion in 2019 to $48.7 billion in 2020, a (2.6%) increase.

Annual Revenue ($)

Novartis revenue was $48.66 b in FY, 2020 which is a (2.6%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$51.9 b$47.45 b$48.66 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$12.69 b$13.16 b$12.78 b$11.11 b$11.76 b$12.17 b$12.28 b$11.35 b$12.26 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Novartis revenue breakdown by business segment: 19.8% from Sandoz and 80.2% from Innovative Medicines

Novartis revenue breakdown by geographic segment: 5.3% from China, 5.8% from Japan , 33.9% from United States, 5.0% from France, 9.3% from Germany and 40.8% from Other

FY, 2020FY, 2018FY, 2019
Sandoz$9.65 b$10.04 b$9.73 b
Innovative Medicines$39.01 b$35.63 b$37.71 b
Alcon$7.15 b
FY, 2020FY, 2018FY, 2019
Japan $2.8 b$3.17 b$2.66 b
Switzerland $800 m$852 m$848 m
United States$16.48 b$17.56 b$16.28 b
Other$19.04 b$22.17 b$21.1 b
France$2.44 b$2.71 b$2.44 b
Germany$4.52 b$4.18 b$4.12 b
United Kingdom$1.26 b
China2.57 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu